Showing results (6931-6940 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|August 29, 2024
Exploring the Inherent Heterogeneity of Vaccine Hesitancy: A Study of a Childhood-Vaccine-Hesitant PopulationMonika Lamot, Andrej Kirbiš, Mitja Vrdelja
Vaccines|August 29, 2024
The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural InfectionWhitney C Weber, Zachary J Streblow, Craig N Kreklywich, et al.
Vaccines|August 29, 2024
The Immunological and Epidemiological Effectiveness of Pediatric Single-Dose Vaccination against Hepatitis A 9 to 11 Years after Its Implementation in the Tyva Republic, the Russian FederationMaria A Lopatukhina, Karen K Kyuregyan, Anastasia A Karlsen, et al.
Vaccines|August 29, 2024
Exploring T-Cell Immunity to Hepatitis C Virus: Insights from Different Vaccine and Antigen Presentation StrategiesGabriel L Costa, Giuseppe A Sautto
Vaccines|August 29, 2024
Correction: Suleman et al. Immunoinformatics and Immunogenetics-Based Design of Immunogenic Peptides Vaccine against the Emerging Tick-Borne Encephalitis Virus (TBEV) and Its Validation through In Silico Cloning and Immune Simulation. Vaccines 2021, 9, 1210Muhammad Suleman, Muhammad Tahir Ul Qamar, Kiran, et al.
Vaccines|August 29, 2024
Hesitancy toward Childhood and Influenza Vaccines: Experiences from Highly Educated Jordanian ParentsMontaha Al-Iede, Mohammad Aljahalin, Eva Fashho, et al.
Vaccines|August 29, 2024
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean RegionManuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Vaccines|August 29, 2024
Using Regular High-Quality Serosurveys to Identify and Close National Immunity Gaps-Measles and Rubella Elimination in JapanTomimasa Sunagawa, Yusuke Kobayashi, Yoshihiro Takashima, et al.
Vaccines|August 29, 2024
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Administered Concomitantly with a 23-Valent Pneumococcal Polysaccharide Vaccine in Adults Aged 60 Years and OlderZhongkui Zhu, Jianwen Sun, Yan Xie, et al.
Vaccines|August 29, 2024
Tracking Measles and Rubella Elimination Progress-World Health Organization African Region, 2022-2023Balcha G Masresha, Charles Shey Wiysonge, Reggis Katsande, et al.
Pageof 1,039